Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A double blind, randomized, placebo controlled, cross-over, Lybridos dose finding study to validate the predictive power of the diagnostic model for Lybrido and Lybridos efficacy and to identify and evaluate additional psychometric and biological markers which increase the predictive power of the diagnostic model, in women with hypoactive sexual desire disorder with or without sexual arousal disorder and/or female orgasmic disorder or SSRI induced sexual dysfunction, in the domestic situation.

Next Previous
Trial Profile

A double blind, randomized, placebo controlled, cross-over, Lybridos dose finding study to validate the predictive power of the diagnostic model for Lybrido and Lybridos efficacy and to identify and evaluate additional psychometric and biological markers which increase the predictive power of the diagnostic model, in women with hypoactive sexual desire disorder with or without sexual arousal disorder and/or female orgasmic disorder or SSRI induced sexual dysfunction, in the domestic situation.

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Jun 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 08 Apr 2014 New source identified and integrated (Netherlands Trial Register; NTR4426)
  • 08 Apr 2014 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top